Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Manami Otsubo"'
Autor:
Yoshihiro Noguchi, Hayato Katsuno, Anri Ueno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Hiroki Esaki, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-8 (2018)
Abstract Background Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GE
Externí odkaz:
https://doaj.org/article/5d608066a8ab424f94ea2ae4f18df0c1
Autor:
Yoshihiro Noguchi, Anri Ueno, Hayato Katsuno, Manami Otsubo, Aki Yoshida, Yuta Kanematsu, Ikuto Sugita, Tomoya Tachi, Teruo Tsuchiya, Hitomi Teramachi
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-7 (2018)
Abstract Background The contents of the guidelines for the use of non-benzodiazepines (Z-drugs) differ slightly between THE JAPANESE SOCIETY OF SLEEP RESEARCH and THE JAPAN GERIATRIC SOCIETY, and the recommended directions are conflicting. Therefore,
Externí odkaz:
https://doaj.org/article/098c3ac2aa214524ba97bbde7f445e30
Autor:
Yoshihiro Noguchi, Anri Ueno, Manami Otsubo, Hayato Katsuno, Ikuto Sugita, Yuta Kanematsu, Aki Yoshida, Hiroki Esaki, Tomoya Tachi, Hitomi Teramachi
Publikováno v:
BMC Bioinformatics, Vol 19, Iss 1, Pp 1-7 (2018)
Abstract Background Patient background (e.g. age, sex, and primary disease) is an important factor to consider when monitoring adverse drug events (ADEs) for the purpose of pharmacovigilance. However, in disproportionality methods, when additional fa
Externí odkaz:
https://doaj.org/article/17029db0859b4bfda098e6b32f16110a
Autor:
Yoshihiro Noguchi, Anri Ueno, Manami Otsubo, Hayato Katsuno, Ikuto Sugita, Yuta Kanematsu, Aki Yoshida, Hiroki Esaki, Tomoya Tachi, Hitomi Teramachi
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Background: Adverse events (AEs) can be caused not only by one drug but also by the interaction between two or more drugs. Therefore, clarifying whether an AE is due to a specific suspect drug or drug-drug interaction (DDI) is useful information for
Externí odkaz:
https://doaj.org/article/3ad1ed43b2c04814a1e1f76d3d1b7f4c
Autor:
Chitoshi Goto, Tomoya Tachi, Manami Otsubo, Satoshi Aoyama, Anri Ueno, Manabu Toyoshima, Hitomi Teramachi, Yoshihiro Noguchi, Hayato Katsuno, Takashi Mizui, Masahiro Yasuda
Publikováno v:
The International Journal of Health Planning and Management. 36:1326-1337
It is important to clarify the influence of activities of daily living (ADL) at discharge on the discharge destination of hospitalised patients. The Functional Independence Measure (FIM) is a widely used ADL assessment scale. In this retrospective st
Publikováno v:
International Journal of Medical Sciences
Introduction: In recent years, there has been an increasing number of people who feel sleep-deprived owing to sudden changes in the social environment. Patients prescribed benzodiazepine-based hypnotics (BZ drugs) also develop movement disorder actio
Autor:
Takashi Niwa, Moeka Yasue, Saki Harada, Yuto Yamada, Manami Otsubo, Michi Yamada, Serika Matsuoka, Taishi Yamamoto, Yurika Mizusaki, Akio Suzuki
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 28(7)
While the revised 2020 consensus guideline recommends the use of area under the concentration-time curve (AUC)-guided vancomycin monitoring, collecting multiple vancomycin serum samples to calculate the AUC may cause clinical complications. The aim o
Autor:
Manabu Toyoshima, Anri Ueno, Yoshihiro Noguchi, Chitoshi Goto, Hayato Katsuno, Hitomi Teramachi, Takashi Mizui, Satoshi Aoyama, Manami Otsubo, Azusa Murayama, Tomoya Tachi, Masahiro Yasuda
Publikováno v:
Aging clinical and experimental research. 33(4)
The Functional Independence Measure (FIM) evaluates the activities of daily living (ADL), and FIM efficiency represents daily improvement in FIM. Polypharmacy affects both ADL and FIM; however, few studies have evaluated its relationship with FIM eff
Autor:
Yuta Kanematsu, Tomoya Tachi, Hitomi Teramachi, Hayato Katsuno, Yoshihiro Noguchi, Teruo Tsuchiya, Anri Ueno, Ikuto Sugita, Manami Otsubo, Hiroki Esaki, Aki Yoshida
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-8 (2018)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background Incretin-based drugs are important in the treatment of type 2 diabetes. However, among the incretin-based drugs, glucagon-like peptide-1 receptor agonists (GLP-1-RAs) have been reported to cause gastroesophageal reflux disease (GERD)-like
Autor:
Aki Yoshida, Hayato Katsuno, Tomoya Tachi, Manami Otsubo, Teruo Tsuchiya, Hitomi Teramachi, Yoshihiro Noguchi, Ikuto Sugita, Yuta Kanematsu, Anri Ueno
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 4, Iss 1, Pp 1-7 (2018)
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences
Background The contents of the guidelines for the use of non-benzodiazepines (Z-drugs) differ slightly between THE JAPANESE SOCIETY OF SLEEP RESEARCH and THE JAPAN GERIATRIC SOCIETY, and the recommended directions are conflicting. Therefore, we analy